A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020

Abstract

Background & objectives: A cluster of SARS-CoV-2 infection occurred among Italian tourists visiting India. We report here the epidemiological, clinical, radiological and laboratory findings of the first cluster of SARS-CoV-2 infection among the tourists. Methods: Information was collected on demographic details, travel and exposure history, comorbidities, timelines of events, date of symptom onset and duration of hospitalization from the 16 Italian tourists and an Indian with laboratory-confirmed SARS-CoV-2 infection. The clinical, laboratory, radiologic and treatment data was abstracted from their medical records and all tourists were followed up till their recovery or discharge or death. Throat and deep nasal swab specimens were collected on days 3, 8, 15, 18, 23 and 25 to evaluate viral clearance. Results: A group of 23 Italian tourists reached New Delhi, India, on February 21, 2020 and along with three Indians visited several tourist places in Rajasthan. By March 3, 2020, 17 of the 26 (attack rate: 65.4%) had become positive for SARS-CoV-2 infection. Of these 17 patients, nine were symptomatic, while eight did not show any symptoms. Of the nine who developed symptoms, six were mild, one was severe and two were critically ill. The median duration between the day of confirmation for COVID-19 and RT-PCR negativity was 18 days (range: 12-23 days). Two patients died with a case fatality of 11.8 per cent. Interpretation & conclusions: This study reconfirms higher rates of transmission among close contacts and therefore, public health measures such as physical distancing, personal hygiene and infection control measures are necessary to prevent transmission. Vivian Thangaraj Jeromie 1 ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu Murhekar Manoj 2 ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu Mehta Yatin 3 Institute of Critical Care & Anaesthesiology, Gurugram, Haryana Kataria Sushila 4 Department of Internal Medicine, Medanta Multi Super-specialty Hospital, Gurugram, Haryana Brijwal Megha 5 Department of Microbiology, All India Institute of Medical Sciences, New Delhi Gupta Nitesh 6 Department of Pulmonary, Critical Care & Sleep Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi Choudhary Aashish 7 Department of Microbiology, All India Institute of Medical Sciences, New Delhi Malhotra Bharati 8 Department of Microbiology, SMS Medical College, Jaipur, Rajasthan Vyas Madhavi 9 Department of Microbiology, SMS Medical College, Jaipur, Rajasthan Sharma Himanshu 10 Department of Microbiology, SMS Medical College, Jaipur, Rajasthan Yadav Naveen 11 ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu Bhatnagar Tarun 12 ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu Gupta Nivedita 13 Epidemiology & Communicable Diseases Division, Indian Council of Medical Research, New Delhi Dar Lalit 14 Department of Microbiology, All India Institute of Medical Sciences, New Delhi Gangakhedkar Raman 15 Epidemiology & Communicable Diseases Division, Indian Council of Medical Research, New Delhi Bhargava Balram 16 Department of Health Research (ICMR), Ministry of Health and Family Welfare, New Delhi Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020; 92 : 401-2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 : 497-506. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it, accessed on April 18, 2020. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-51. Geneva: WHO; 2020. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-101. Geneva: WHO; 2020. Ministry of Health & Family Welfare, Government of India. COVID-19 India update. Available from: https://www.mohfw.gov.in/">https://www.mohfw.gov.in/, accessed on May 1, 2020. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020; 395 : 514-23. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382 : 1199-207. Gupta N, Potdar V, Praharaj I, Giri S, Sapkal G, Yadav P, et al. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res 2020; 151 : 216-25 Yu P, Zhu J, Zhang Z, Han Y. Familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. Infect Dis 2020; 221 : 1757-61. World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report-32. Geneva: WHO; 2020. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries 2020; 14 : 125-8. Moriarty LF, Plucinski MM, Marston BJ, Kurbatova EV, Knust B, Murray EL, et al. Public health responses to COVID-19 outbreaks on cruise ships-Worldwide, February-March 2020. MMWR Morb Mortal Wkly Rep 2020; 69 : 347-52. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323 : 1061-9. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41 : 145-51. Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020; 127 : 104370. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020; 84 : 106504. Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect 2020. pii: S0399-077X(20)30086-X.